Does TELAPREVIR Cause Hepatocellular carcinoma? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Hepatocellular carcinoma have been filed in association with TELAPREVIR. This represents 0.3% of all adverse event reports for TELAPREVIR.
20
Reports of Hepatocellular carcinoma with TELAPREVIR
0.3%
of all TELAPREVIR reports
8
Deaths
6
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From TELAPREVIR?
Of the 20 reports, 8 (40.0%) resulted in death, 6 (30.0%) required hospitalization.
Is Hepatocellular carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TELAPREVIR. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does TELAPREVIR Cause?
Anaemia (1,124)
Rash (918)
Nausea (823)
Fatigue (793)
Pruritus (652)
Headache (506)
Pyrexia (435)
Insomnia (399)
Vomiting (376)
Diarrhoea (337)
What Other Drugs Cause Hepatocellular carcinoma?
SORAFENIB (1,665)
RIBAVIRIN (1,046)
SOFOSBUVIR (877)
LEDIPASVIR\SOFOSBUVIR (640)
BEVACIZUMAB (532)
REGORAFENIB (470)
DACLATASVIR (419)
ATEZOLIZUMAB (342)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
Which TELAPREVIR Alternatives Have Lower Hepatocellular carcinoma Risk?
TELAPREVIR vs TELBIVUDINE
TELAPREVIR vs TELMISARTAN
TELAPREVIR vs TELOTRISTAT ETHYL
TELAPREVIR vs TEMAZEPAM
TELAPREVIR vs TEMODAR